Quadruple Therapies and the Future of Multiple Myeloma Treatment
Sylvester Comprehensive Cancer CenterASCO: Treatment options for multiple myeloma are shifting rapidly, with new patients increasingly being treated with a 4-part drug combination that includes a new immunotherapy agent. What does this mean for patients, and how will treatment change in the future?